Stay updated on Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial
Sign up to get notified when there's something new on the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page.

Latest updates to the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page shows a new document revision, updating from v3.6.2 to v3.6.3 for the study documents.SummaryDifference0.1%

- Check23 days agoChange DetectedThe page shows an updated revision tag from v3.6.0 to v3.6.2. This indicates a minor update to the page's content or layout rather than a substantive change to study information.SummaryDifference0.1%

- Check38 days agoChange DetectedRecruitment status now indicates the study is closed to new participants. The page adds several informational sections (How to Read a Study Record, Common Questions, How to Join a Study) and an Intervention/Treatment section, and updates the revision to v3.6.0 while removing the previous label and v3.5.5 reference.SummaryDifference0.4%

- Check45 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 in the page footer, reflecting a new page version. This change does not alter the study content or visible features.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page's Revision tag changed from v3.5.3 to v3.5.4, representing a new edition of the page; this appears to be a maintenance update rather than a substantive content modification.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page’s footer/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a website release change rather than any update to the clinical study details.SummaryDifference0.1%

Stay in the know with updates to Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page.